APL is a subtype of acute myeloid leukemia (AML) that is genetically characterized by a specific chromosomal translocation that yields the promyelotic leukemia/retinoic acid receptor alpha (PML/RARA) fusion gene—a DNA-binding transcription factor [8]. The gene discussed is RARA; the disease is acute promyelocytic leukemia.